Glucagon and Glucagon Receptor Agents
2 compounds in this family, each with its recorded mechanism, routes of administration, safety notes and references to published literature.
- DasiglucagonDasiglucagon is a synthetic analogue of human glucagon that has been formulated for ready‑to‑use subcutaneous injection. It is approved in the United States for the rapid treatment of severe hypoglycaemia in patients with diabetes, including children aged six years and older. By replacing the deficient endogenous glucagon during insulin‑induced low blood glucose, dasiglucagon quickly restores normal plasma glucose levels without the need for reconstitution.
- GlucagonGlucagon is an approved peptide hormone that acts as an agonist at the glucagon receptor. It belongs to the glucagon and glucagon receptor agents family and is prescribed for clinical use. The drug is supplied in injectable forms (intramuscular, intravenous, subcutaneous) and as a nasal preparation. Its pharmacologic role is to activate hepatic glucagon receptors, leading to metabolic effects that raise blood glucose. Glucagon is marketed under several names, including Baqsimi, GlucaGen, and as part of emergency kits.